Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro

Purpose. To investigate the mechanism of action in peripheral tissues of novel complex drug containing release-active dilutions of antibodies to the beta subunit of the insulin receptor and antibodies to endothelial nitric oxide synthase (Subetta), which has shown efficacy in animal models of diabet...

Full description

Saved in:
Bibliographic Details
Main Authors: Jim Nicoll, Evgeniy A. Gorbunov, Sergey A. Tarasov, Oleg I. Epstein
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2013/925874
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565657819938816
author Jim Nicoll
Evgeniy A. Gorbunov
Sergey A. Tarasov
Oleg I. Epstein
author_facet Jim Nicoll
Evgeniy A. Gorbunov
Sergey A. Tarasov
Oleg I. Epstein
author_sort Jim Nicoll
collection DOAJ
description Purpose. To investigate the mechanism of action in peripheral tissues of novel complex drug containing release-active dilutions of antibodies to the beta subunit of the insulin receptor and antibodies to endothelial nitric oxide synthase (Subetta), which has shown efficacy in animal models of diabetes. Methods. Human mature adipocytes were incubated either with Subetta, with one of negative controls (placebo or vehicle), with one of nonspecific controls (release-active dilutions of antibodies to cannabinoid receptor type I or release-active dilutions of rabbit nonimmune serum), or with dimethyl sulfoxide (DMSO) at 37°C in a humidified incubator at 5% CO2 for three days. Rosiglitazone was used as reference drug. Secretion of adiponectin was measured by quantitative enzyme-linked immunosorbent assay (ELISA). Results. Only Subetta significantly stimulates adiponectin production by mature human adipocytes. Nonspecific controls did not significantly affect adiponectin secretion, resulting in adiponectin levels comparable to background values of the negative controls and DMSO. Conclusion. Increasing adiponectin production in absence of insulin by Subetta probably via modulating effect on the beta subunit of the insulin receptor might serve as one of the mechanisms of the antidiabetic effect of this drug. These in vitro results give first insight on possible mechanism of action of Subetta and serve as a background for further studies.
format Article
id doaj-art-883a154d24fe4d4b97baeada8fe84936
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-883a154d24fe4d4b97baeada8fe849362025-02-03T01:07:03ZengWileyInternational Journal of Endocrinology1687-83371687-83452013-01-01201310.1155/2013/925874925874Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In VitroJim Nicoll0Evgeniy A. Gorbunov1Sergey A. Tarasov2Oleg I. Epstein3Zen-Bio, Inc., 3200 Chapel Hill-Nelson Boulevard, Street 100, Research Triangle Park, NC 27709, USAOOO “NPF “MATERIA MEDICA HOLDING”, 3rd Samotyochny per., 9, Moscow 127473, RussiaOOO “NPF “MATERIA MEDICA HOLDING”, 3rd Samotyochny per., 9, Moscow 127473, RussiaOOO “NPF “MATERIA MEDICA HOLDING”, 3rd Samotyochny per., 9, Moscow 127473, RussiaPurpose. To investigate the mechanism of action in peripheral tissues of novel complex drug containing release-active dilutions of antibodies to the beta subunit of the insulin receptor and antibodies to endothelial nitric oxide synthase (Subetta), which has shown efficacy in animal models of diabetes. Methods. Human mature adipocytes were incubated either with Subetta, with one of negative controls (placebo or vehicle), with one of nonspecific controls (release-active dilutions of antibodies to cannabinoid receptor type I or release-active dilutions of rabbit nonimmune serum), or with dimethyl sulfoxide (DMSO) at 37°C in a humidified incubator at 5% CO2 for three days. Rosiglitazone was used as reference drug. Secretion of adiponectin was measured by quantitative enzyme-linked immunosorbent assay (ELISA). Results. Only Subetta significantly stimulates adiponectin production by mature human adipocytes. Nonspecific controls did not significantly affect adiponectin secretion, resulting in adiponectin levels comparable to background values of the negative controls and DMSO. Conclusion. Increasing adiponectin production in absence of insulin by Subetta probably via modulating effect on the beta subunit of the insulin receptor might serve as one of the mechanisms of the antidiabetic effect of this drug. These in vitro results give first insight on possible mechanism of action of Subetta and serve as a background for further studies.http://dx.doi.org/10.1155/2013/925874
spellingShingle Jim Nicoll
Evgeniy A. Gorbunov
Sergey A. Tarasov
Oleg I. Epstein
Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
International Journal of Endocrinology
title Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
title_full Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
title_fullStr Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
title_full_unstemmed Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
title_short Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
title_sort subetta treatment increases adiponectin secretion by mature human adipocytes in vitro
url http://dx.doi.org/10.1155/2013/925874
work_keys_str_mv AT jimnicoll subettatreatmentincreasesadiponectinsecretionbymaturehumanadipocytesinvitro
AT evgeniyagorbunov subettatreatmentincreasesadiponectinsecretionbymaturehumanadipocytesinvitro
AT sergeyatarasov subettatreatmentincreasesadiponectinsecretionbymaturehumanadipocytesinvitro
AT olegiepstein subettatreatmentincreasesadiponectinsecretionbymaturehumanadipocytesinvitro